23 results on '"Zielinski C"'
Search Results
2. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment
3. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
4. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS)
5. Presence of varicose veins in cancer patients increases the risk for occurrence of venous thromboembolism
6. Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
7. Thrombosis risk and survival in cancer patients with elevated C‐reactive protein
8. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
9. A network meta-analysis comparing the efficacy and safety of anticoagulants for the treatment of venous thromboembolism in cancer patients: OR260
10. Biomarkers predictive of venous thromboembolism in patients with high grade gliomas: PB 3.60–2
11. Association of interleukins with venous thromboembolism and mortality in cancer patients: PA 1.16–5
12. Association of mean platelet volume with cancer-associated venous thromboembolism: results from the vienna cancer and thrombosis study (CATS): OC 31.1
13. Urokinase-type plasminogen activator receptor (uPAR) regulates angiogenesis via interaction with low density lipoprotein receptor-(LDLR-) like proteins: DC.01
14. Urokinase receptor (UPAR) mediated integrin redistribution represents a central mechanism for growth factor induced endothelial cell migration: O-TH-120
15. Urokinase plasminogen activator receptor (UPAR) regulates angiogenesis via direct interaction with low density lipoprotein receptor (LDLR-) like protein in endothelial cells: O-WE-044
16. Microparticle-associated tissue factor activity in pancreatic- and brain cancer patients: impact on thrombosis risk and survival: O-WE-037
17. Growth factor induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution: O5B-5
18. uPAR/LDLR interaction: a novel target for efficient endothelial cell migration: O5B-4
19. Tumor blood vessel formation is affected by the human carcinoembryonic antigen (CEA): OC-WE-069
20. Biomarkers improve the risk scoring model for prediction of cancer-associated thrombosis: OC-TU-016
21. Prediction of venous thromboembolism in cancer patients by measuring thrombin generation -results from the vienna cancer and thrombosis study (CATS): OC-TU-015
22. Elevated C-reactive protein (CRP) levels are associated with risk of occurrence of venous thromboembolism (VTE) in cancer patients - results from the vienna cancer and thrombosis study (CATS): OC-TU-013
23. A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.